|
Volumn 50, Issue 2, 2010, Pages 290-291
|
The expanding range and severity of babesiosis
|
Author keywords
[No Author keywords available]
|
Indexed keywords
RITUXIMAB;
MONOCLONAL ANTIBODY;
AGED;
AMBLYOMMA;
ANAMNESIS;
ARTICLE;
BABESIA MICROTI;
BABESIOSIS;
BLOOD SMEAR;
BLOOD TRANSFUSION;
CASE REPORT;
CLINICAL FEATURE;
DISEASE SEVERITY;
DISEASE TRANSMISSION;
FEMALE;
HUMAN;
IMMUNOCOMPROMISED PATIENT;
INCIDENCE;
LIFE CYCLE;
LYMPHOPROLIFERATIVE DISEASE;
NONHUMAN;
PEROMYSCUS;
RISK FACTOR;
UNITED STATES;
VOLE;
ACUTE KIDNEY FAILURE;
ANIMAL;
BITES AND STINGS;
BLOOD;
COMMUNICABLE DISEASE;
DISEASE CARRIER;
ERYTHROCYTE;
GROWTH, DEVELOPMENT AND AGING;
HEMOLYTIC ANEMIA;
ISOLATION AND PURIFICATION;
PARASITE VECTOR;
PARASITOLOGY;
RENAL REPLACEMENT THERAPY;
RODENT;
SALIVARY GLAND;
TICK;
ULTRASTRUCTURE;
AGED, 80 AND OVER;
ANEMIA, HEMOLYTIC;
ANIMALS;
ANTIBODIES, MONOCLONAL;
ARACHNID VECTORS;
BABESIA MICROTI;
BABESIOSIS;
BITES AND STINGS;
BLOOD TRANSFUSION;
COMMUNICABLE DISEASES, EMERGING;
DISEASE RESERVOIRS;
ERYTHROCYTES;
FEMALE;
HUMANS;
IMMUNOCOMPROMISED HOST;
IXODIDAE;
KIDNEY FAILURE, ACUTE;
LYMPHOPROLIFERATIVE DISORDERS;
MARYLAND;
RENAL DIALYSIS;
RODENTIA;
SALIVARY GLANDS;
|
EID: 75749136471
PISSN: 00411132
EISSN: 15372995
Source Type: Journal
DOI: 10.1111/j.1537-2995.2009.02563.x Document Type: Article |
Times cited : (6)
|
References (3)
|